[1]
Yilmaz, M., Yaşar, E., Ayli, B.I., Gok Oguz, E. and Ayli, M.D. 2026. Comparison of Dapagliflozin and Empagliflozin in Patients with Type 2 Diabetes and/or Chronic Kidney Disease: A Real-World Observational Study: Dapagliflozin vs Empagliflozin. Journal of European Internal Medicine Professionals. 4, 1 (Feb. 2026), 7–12. DOI:https://doi.org/10.5281/zenodo.18442723.